Log in to save to my catalogue

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eda4a3f9b12d41b09208b0a6db4d04c4

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis

About this item

Full title

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis

Publisher

England: BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2023-03, Vol.19 (1), p.20-20, Article 20

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Subcutaneous immunotherapy (SCIT) is a well-validated and effective disease modification treatment for house dust mites (HDM)-induced allergic rhinitis (AR). Long-term post-treatment comparisons in children and adults treated with SCIT have rarely been published. This study aimed to evaluate the long-term efficacy of HDM-SCIT administered under a c...

Alternative Titles

Full title

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eda4a3f9b12d41b09208b0a6db4d04c4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eda4a3f9b12d41b09208b0a6db4d04c4

Other Identifiers

ISSN

1710-1492,1710-1484

E-ISSN

1710-1492

DOI

10.1186/s13223-023-00781-8

How to access this item